Vyndaqel 20 MG capsule UD 120S
Ended Awarded Last action
- Contract number
- SPE2DR26FYA9S
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,593
Award facts
- Contract value 100% obligated
- $14,592.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 29, 2026, the Defense Logistics Agency awarded a delivery order valued at $14,592.58 to AmerisourceBergen Drug Corp for the supply of Vyndaqel 20 mg capsule unit dose packages (120 count). This firm fixed-price, non-set-aside contract is scheduled for completion by February 20, 2026, with performance at the awardee's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical federal healthcare vendor that supplies an extensive range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company maintains significant contract relationships with the Defense Logistics Agency and serves military treatment facilities, veterans' healthcare programs, and other federal medical institutions. Vyndaqel (diflunisal derivative) is a cardiac medication used in treating certain types of heart failure, reflecting the company's role in supplying specialized pharmaceuticals to support military and federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FYA9S?
SPE2DR26FYA9S was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FYA9S worth?
The government has obligated $14,593 on SPE2DR26FYA9S.
Is contract SPE2DR26FYA9S an order under another contract?
Yes. SPE2DR26FYA9S is a delivery order under SPE2DR25D6044, an indefinite delivery contract.
Was contract SPE2DR26FYA9S competed?
The extent of competition for SPE2DR26FYA9S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award